Work

Routine laboratory trajectories predict organ-level complications in cancer

Year: 2026
Type: article
Abstract: Routine laboratory panels drawn during cancer treatment constitute longitudinal physiological recordings of organ function, yet their temporal structure is discarded by single-timepoint prognostic tools. A transformer trained on 2,777,595 laboratory measurements from 3905 patients with multiple myeloma or ovarian cancer predicted which of 162 treatment-associated complications would be newly recorded within two years, spanning eight clinical categories, achieving 1.5- to 6.1-fold enrichment above prevalence. Across individual endpoints it exceeded non-sequential baselines, including engineered-trajectory models, by +0.024 to +0.070 in mean AUROC. Predictions generalised across both cancers, divergence concentrating in disease-specific complications, and biomarker masking recovered signatures consistent with established pathophysiology. External validation on MIMIC-IV and MMRF CoMMpass showed transferability, strongest for renal and metabolic endpoints, attenuated for infection endpoints. On CoMMpass it added prognostic value to ISS staging. Routine oncological laboratory data carry complication-specific physiological signal months before a complication is recorded, and require no testing beyond standard oncological care.
Language: English
Open Access status: gold
Estimated APC paid: $4,090
OpenAlex ID: W7163984111
FWCI:
Cites: 52
Cited by:
Related to: 10